Bicycle Therapeutics to Participate in the SVB Securities Global Biopharma Conference

Author's Avatar
Feb 08, 2023

Bicycle+Therapeutics+plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in a fireside chat at the SVB Securities Global Biopharma Conference on February 15th, 2023 at 9:20 a.m. ET. The conference will be held in a virtual meeting format.